MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Canadian-based Mackie Research Capital Corporation has been appointed as lead manager for the equity financing component of the Company's proposed TSX-V listing.
MMJ PhytoTech Limited (ASX:MMJ) wishes to advise that it is fully supportive of recent amendments to Australian Commonwealth legislation, legalising cannabis-based products for medicinal or research purposes as controlled drugs.
MMJ PhytoTech Ltd (ASX:MMJ) advises that it has executed a binding Term Sheet with Canadian-based Harvest One Capital Corp. for the sale to Harvest One of 100% of the issued shares of United Greeneries Holdings Ltd and Satipharm AG respectively.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 30 September 2016.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the company's Annual Report to shareholders.
Anatara Lifesciences Ltd (ASX:ANR) directors present their report on the consolidated entity consisting of Anatara Lifesciences Ltd and the entities it controlled at the end of, or during, the year ended 30 June 2016.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that it has received $420,460 from the Australian Tax Office for the Research and Development (R&D) Tax Incentive. This refund is from Anatara's 2014-15 research activities and future refunds will increase significantly. The company is in the process of finalising its 2015-16 tax claim.
